2005
DOI: 10.1080/09638280400014592
|View full text |Cite
|
Sign up to set email alerts
|

Theoretical and methodological considerations in the measurement of spasticity

Abstract: Methods appropriate for use in research, particularly into the mechanism of spasticity did not satisfy the needs of the clinician and the need for an objective but clinically applicable tool was identified. A clinical assessment may need to generate more than one 'value' and should include evaluation of other components of the upper motor neurone syndrome. There is therefore a need for standardized protocols for 'best practice' in application of spasticity measurement tools and scales.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
174
0
21

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 216 publications
(196 citation statements)
references
References 29 publications
1
174
0
21
Order By: Relevance
“…The increase in X V3 in ankle plantarflexors was 6.8° in the 10 U/kg/ leg group and 10.9° in the 15 U/kg/ leg group. As such, we agree with recommendations to use more than just the MAS in the assessment of spasticity 22,23 and confirm the utility 6 by guest on May 12, 2018 http://pediatrics.aappublications.org/ Downloaded from of the Tardieu Scale in pediatric clinical assessment of spasticity. Improvements in muscle tone at both abobotulinumtoxinA doses at week 4 were also associated with a significant overall clinical improvement based on the PGA, and PGA scores were still highly significant at week 12 indicating a carryover of benefit beyond the duration of BoNT-A action.…”
Section: Discussionmentioning
confidence: 72%
“…The increase in X V3 in ankle plantarflexors was 6.8° in the 10 U/kg/ leg group and 10.9° in the 15 U/kg/ leg group. As such, we agree with recommendations to use more than just the MAS in the assessment of spasticity 22,23 and confirm the utility 6 by guest on May 12, 2018 http://pediatrics.aappublications.org/ Downloaded from of the Tardieu Scale in pediatric clinical assessment of spasticity. Improvements in muscle tone at both abobotulinumtoxinA doses at week 4 were also associated with a significant overall clinical improvement based on the PGA, and PGA scores were still highly significant at week 12 indicating a carryover of benefit beyond the duration of BoNT-A action.…”
Section: Discussionmentioning
confidence: 72%
“…18 Although the Modified Ashworth Scale is used to measure spasticity in clinical practice and research studies, it measures muscle tone rather than spasticity. The scale has been validated to measure muscle tone at the elbow 121 and although it has been used in some studies to measure tone at other upper limb joints it is unclear how this was undertaken.…”
Section: Measurement Of Spasticitymentioning
confidence: 99%
“…16 Despite the lack of prevalence or prospective cohort studies, upper Because of the complex multifaceted definition, measurement of spasticity is a challenge and no tool covers all aspects of the definition. 18 Clinicians and researchers often measure resistance to passive movement (muscle tone) using a clinical assessment scale, e.g. the Modified Ashworth Scale.…”
Section: Spasticitymentioning
confidence: 99%
“…As a consequence, many studies have been conducted using biomechanical and electrophysiological measurements with the objective of evaluating spasticity, and the obtained results have been used to make correlations with the clinical scales (8)(9)(10)(11)(12)(13)(14). Surface electromyography (EMG) has been commonly used in electrophysiological measurements of spasticity (14)(15)(16). However, parameters extracted from surface EMG have been generally obtained from analysis by using only the time domain in previous studies, and results were generally based on correlations with the clinical scales rather than using stand-alone surface EMG as well as considering causality.…”
Section: Introductionmentioning
confidence: 99%